Long-Term Efficacy and Safety of Rifaximin in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study

Background: Rifaximin is commonly used for hepatic encephalopathy (HE). However, the effects of long-term treatment for Japanese people are limited. Therefore, this study aimed to investigate the effects and safety of long-term treatment with rifaximin on HE. Methods: A total of 215 patients with ci...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawaratani, Hideto, Kondo, Yasuteru, Tatsumi, Ryoji, Kawabe, Naoto, Tanabe, Norikazu, Sakamaki, Akira, Okumoto, Kazuo, Uchida, Yoshihito, Endo, Kei, Kawaguchi, Takumi, Oikawa, Tsunekazu, Ishizu, Yoji, Hige, Shuhei, Takami, Taro, Terai, Shuji, Ueno, Yoshiyuki, Mochida, Satoshi, Takikawa, Yasuhiro, Torimura, Takuji, Matsuura, Tomokazu, Ishigami, Masatoshi, Koike, Kazuhiko, Yoshiji, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948903/
https://www.ncbi.nlm.nih.gov/pubmed/35329897
http://dx.doi.org/10.3390/jcm11061571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948903/
https://www.ncbi.nlm.nih.gov/pubmed/35329897
http://dx.doi.org/10.3390/jcm11061571

Ejemplares similares